Check out Pascal Zutas' winning presentation on stage and the judges' feedbackRead more...
Check out Giangiacomo Rocco di Torrepadulas' winning presentation on stage and the judges' feedback
Amicomed address B2B customers that can receive tangible clinical and economic benefits from their outcomes. Amicomed will first target care-providers linked to quality metrics (e.g. ACOs, BPCI), impacting positively their quality scores, avoiding losses/gaining benefits (hence willing to pay for Amicomed). Once they have built more evidence as they grow, Amicomed will start targeting payers, including CMS, increasing potential users and improving the service
Among the judges were Risa Stack (General Manager, GE Ventures), Emily Melton (Partner, DFJ Venture), Paul Willard (Partner, Subtraction Capital), Hubert Zajicek (CEO, Health Wildcatters)
Thanks to Splash Health 2017 sponsors: Advsr, AARP, Avison Young, Bread and Butter Wine, Silicon Valley Bank, Surf Air, Stratpoint, Silicon Valley Bank and Scrubbed. Remember! If you want to invest in startups selected by Vator, join the Vator Investment Club.
Read more from our "Vator Splash Startup Finalists/Winners" series
Check out Aron Rachamims' winning presentation on stage and the judges' feedbackRead more...
Check out Cory Kidds' winning presentation on stage and the judges' feedbackRead more...
Related Companies, Investors, and Entrepreneurs
Joined Vator on
Amicomed is the first fully automated digital therapeutics platform for Blood Pressure (BP) management combining innovative remote monitoring and lifestyle intervention.
Amicomed leverages proprietary algorithms to provide tangible outcomes through innovative management of blood pressure. The platform supports physicians and patients with remote monitoring tools enhanced by unprecedented blood pressure data analysis, and an actionable, consumer-grade designed, personalized lifestyle intervention.
Amicomed's results have been striking: 70% adherence with a mean BP reduction (sys) of 5mmHg (up to 20mmHg) with seven proof points at major international congresses (American Heart Association, American Society of Hypertension, American College of Cardiology, European Society of Hypertension, etc).
Joined Vator on
Subtraction Capital is an opportunistic venture fund that works hard to support great entrepreneurs. We believe that we have an eye for spotting valuable companies early in their lifecycle, but we also invest in mid and late stage companies that have proven track records and more established teams.
Joined Vator onSerial entrepreneur passionate for startups. MBA (Bocconi), McKinsey. In 2000 cofounded Pharmaidea (at his exit fully profitable, €150 mln rev, and 150 employees). Now cofounder and CEO of Amicomed, digital platform for blood pressure management
Joined Vator onIn1996 I founded of Telbios (today serving tens of thousands of chronic patients), then responsible for the E2E service design in the largest European initiative of Population management. Mentor at Stanford at the class 'Biodesign for mobile health.
Joined Vator onLecturer in Cardiovascular Medicine and Director Cardiovascular Prevention and Rehabilitation Unit at San Raffaele Hospital Founding Member International Heart Health Society Experience in Health IT, founding member Health On The Net (Geneva)
Joined Vator onCo-founded Health Wildcatters, which I also run. I specialize in healthcare companies / startups (digital health/ mHealth / medical device companies) where I have spent most of my time.